Status:
COMPLETED
Intrathecal Pethidine Plus Dexamethasone for Distal Lower Orthopedic Surgeries
Lead Sponsor:
Zagazig University
Conditions:
Postoperative Pain
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
Bupivacaine is commonly used as a sole agent for spinal anesthesia unlike pethidine. Pethidine (meperidine) is a unique opioid. In addition to its analgesic activity, it also has significant local ane...
Detailed Description
pethidine compared favorably with bupivacaine as the sole anesthetic agent, providing excellent conditions for lower abdominal and pelvic surgery. Some studies showed that intrathecal pethidine has sh...
Eligibility Criteria
Inclusion
- Patient acceptance.
- Patients scheduled for lower extremity orthopedic surgery
- Both sex
- Patient's age \>18 years.
- Patients with American Society of Anaesthesia (ASA)physical status I, II.
Exclusion
- Patient's age ≤18 years.
- Uncooperative patients and patients with psychological problems.
- Patients with contraindications to spinal anesthesia.
- Patients with contraindications to bupivacaine or dexamethasone or pethidine.
- Patients with ASA physical status III and IV.
- Morbid obesity (BMI \>35).
Key Trial Info
Start Date :
January 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2024
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT05303311
Start Date
January 15 2022
End Date
March 15 2024
Last Update
July 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine , Zagazig University
Zagazig, Sharqia Province, Egypt, 44511